153 related articles for article (PubMed ID: 22272199)
1. Vascular disrupting agent arsenic trioxide enhances thermoradiotherapy of solid tumors.
Griffin RJ; Williams BW; Koonce NA; Bischof JC; Song CW; Asur R; Upreti M
J Oncol; 2012; 2012():934918. PubMed ID: 22272199
[TBL] [Abstract][Full Text] [Related]
2. Study of arsenic trioxide-induced vascular shutdown and enhancement with radiation in solid tumor.
Monzen H; Griffin RJ; Williams BW; Amano M; Ando S; Hasegawa T
Radiat Med; 2004; 22(4):205-11. PubMed ID: 15468939
[TBL] [Abstract][Full Text] [Related]
3. Use of arsenic trioxide as an antivascular and thermosensitizing agent in solid tumors.
Griffin RJ; Lee SH; Rood KL; Stewart MJ; Lyons JC; Lew YS; Park H; Song CW
Neoplasia; 2000; 2(6):555-60. PubMed ID: 11228548
[TBL] [Abstract][Full Text] [Related]
4. Arsenic Trioxide as a Vascular Disrupting Agent: Synergistic Effect with Irinotecan on Tumor Growth Delay in a CT26 Allograft Model.
Lee JC; Lee HY; Moon CH; Lee SJ; Lee WH; Cha HJ; Park S; Lee YH; Park HJ; Song HT; Min YJ
Transl Oncol; 2013 Feb; 6(1):83-91. PubMed ID: 23418620
[TBL] [Abstract][Full Text] [Related]
5. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
Ning S; Knox SJ
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
[TBL] [Abstract][Full Text] [Related]
6. Arsenic trioxide induces selective tumour vascular damage via oxidative stress and increases thermosensitivity of tumours.
Griffin RJ; Monzen H; Williams BW; Park H; Lee SH; Song CW
Int J Hyperthermia; 2003; 19(6):575-89. PubMed ID: 14756449
[TBL] [Abstract][Full Text] [Related]
7. Combination of arsenic trioxide and chemotherapy in small cell lung cancer.
Zheng CY; Lam SK; Li YY; Fong BM; Mak JC; Ho JC
Lung Cancer; 2013 Nov; 82(2):222-30. PubMed ID: 24041618
[TBL] [Abstract][Full Text] [Related]
8. Effects of hyperthermia, radiotherapy and thermoradiotherapy on tumor microvascular permeability.
Fujiwara K; Watanabe T
Acta Pathol Jpn; 1990 Feb; 40(2):79-84. PubMed ID: 2160185
[TBL] [Abstract][Full Text] [Related]
9. [Experimental study of the anti-tumor effect of arsenic trioxide or thalidomide alone and combination of both for treatment of myelodysplastic syndrome model].
Lu J; Jin J; Xu WL
Zhonghua Er Ke Za Zhi; 2006 Mar; 44(3):228-33. PubMed ID: 16624066
[TBL] [Abstract][Full Text] [Related]
10. Use of a fluorescently labeled poly-caspase inhibitor for in vivo detection of apoptosis related to vascular-targeting agent arsenic trioxide for cancer therapy.
Griffin RJ; Williams BW; Bischof JC; Olin M; Johnson GL; Lee BW
Technol Cancer Res Treat; 2007 Dec; 6(6):651-4. PubMed ID: 17994796
[TBL] [Abstract][Full Text] [Related]
11. Thermoradiotherapy with hydralazine: the effect of preirradiation of the tumor bed on blood flow and growth delay of Ehrlich carcinoma.
Kozin SV; Kozina LV
Radiat Res; 1999 Jan; 151(1):79-84. PubMed ID: 9973088
[TBL] [Abstract][Full Text] [Related]
12. Synergistic interaction with arsenic trioxide and fractionated radiation in locally advanced murine tumor.
Lew YS; Kolozsvary A; Brown SL; Kim JH
Cancer Res; 2002 Aug; 62(15):4202-5. PubMed ID: 12154019
[TBL] [Abstract][Full Text] [Related]
13. Cryptotanshinone enhances the effect of Arsenic trioxide in treating liver cancer cell by inducing apoptosis through downregulating phosphorylated- STAT3 in vitro and in vivo.
Shen L; Zhang G; Lou Z; Xu G; Zhang G
BMC Complement Altern Med; 2017 Feb; 17(1):106. PubMed ID: 28187727
[TBL] [Abstract][Full Text] [Related]
14. Intravenous administration of arsenic trioxide encapsulated in liposomes inhibits the growth of C6 gliomas in rat brains.
Zhao S; Zhang X; Zhang J; Zhang J; Zou H; Liu Y; Dong X; Sun X
J Chemother; 2008 Apr; 20(2):253-62. PubMed ID: 18467254
[TBL] [Abstract][Full Text] [Related]
15. TG-interacting factor transcriptionally induced by AKT/FOXO3A is a negative regulator that antagonizes arsenic trioxide-induced cancer cell apoptosis.
Liu ZM; Tseng HY; Cheng YL; Yeh BW; Wu WJ; Huang HS
Toxicol Appl Pharmacol; 2015 May; 285(1):41-50. PubMed ID: 25791921
[TBL] [Abstract][Full Text] [Related]
16. Combination of Arsenic Trioxide and Valproic Acid Efficiently Inhibits Growth of Lung Cancer Cells via G2/M-Phase Arrest and Apoptotic Cell Death.
Park HK; Han BR; Park WH
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32290325
[TBL] [Abstract][Full Text] [Related]
17. Metformin potentiates the effect of arsenic trioxide suppressing intrahepatic cholangiocarcinoma: roles of p38 MAPK, ERK3, and mTORC1.
Ling S; Xie H; Yang F; Shan Q; Dai H; Zhuo J; Wei X; Song P; Zhou L; Xu X; Zheng S
J Hematol Oncol; 2017 Feb; 10(1):59. PubMed ID: 28241849
[TBL] [Abstract][Full Text] [Related]
18. Optimization of combination therapy of arsenic trioxide and fractionated radiotherapy for malignant glioma.
Ning S; Knox SJ
Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):493-8. PubMed ID: 16563655
[TBL] [Abstract][Full Text] [Related]
19. Delivery of Arsenic Trioxide by Multifunction Nanoparticles To Improve the Treatment of Hepatocellular Carcinoma.
Wu Q; Chen X; Wang P; Wu Q; Qi X; Han X; Chen L; Meng X; Xu K
ACS Appl Mater Interfaces; 2020 Feb; 12(7):8016-8029. PubMed ID: 31997633
[TBL] [Abstract][Full Text] [Related]
20. Double-Sided Personality: Effects of Arsenic Trioxide on Inflammation.
Zhang J; Zhang Y; Wang W; Li C; Zhang Z
Inflammation; 2018 Aug; 41(4):1128-1134. PubMed ID: 29629493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
